- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.90 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x CPR: 6-CHLOROPURINE RIBOSIDE, 5'-MONOPHOSPHATE(Covalent)
- 4 x SAE: SELENAZOLE-4-CARBOXYAMIDE-ADENINE DINUCLEOTIDE(Non-covalent)
SAE.2: 14 residues within 4Å:- Chain A: T.252, H.253, D.274, S.275, S.276, F.282, N.303, G.324, Q.334, D.364
- Chain D: T.45, H.466, Q.469
- Ligands: CPR.1
15 PLIP interactions:11 interactions with chain A, 4 interactions with chain D- Hydrogen bonds: A:H.93, A:T.252, A:T.252, A:S.276, A:N.303, A:Q.334, A:D.364, D:Q.469
- pi-Stacking: A:H.253, A:H.253, A:F.282, A:F.282
- Water bridges: D:A.46, D:A.46
- Salt bridges: D:H.466
SAE.19: 14 residues within 4Å:- Chain B: T.252, H.253, D.274, S.275, S.276, F.282, N.303, G.324, Q.334, D.364
- Chain C: T.45, H.466, Q.469
- Ligands: CPR.18
15 PLIP interactions:4 interactions with chain C, 11 interactions with chain B- Hydrogen bonds: C:Q.469, B:H.93, B:T.252, B:T.252, B:S.276, B:N.303, B:Q.334, B:D.364
- Water bridges: C:A.46, C:A.46
- Salt bridges: C:H.466
- pi-Stacking: B:H.253, B:H.253, B:F.282, B:F.282
SAE.36: 14 residues within 4Å:- Chain A: T.45, H.466, Q.469
- Chain C: T.252, H.253, D.274, S.275, S.276, F.282, N.303, G.324, Q.334, D.364
- Ligands: CPR.35
15 PLIP interactions:11 interactions with chain C, 4 interactions with chain A- Hydrogen bonds: C:H.93, C:T.252, C:T.252, C:S.276, C:N.303, C:Q.334, C:D.364, A:Q.469
- pi-Stacking: C:H.253, C:H.253, C:F.282, C:F.282
- Water bridges: A:A.46, A:A.46
- Salt bridges: A:H.466
SAE.53: 14 residues within 4Å:- Chain B: T.45, H.466, Q.469
- Chain D: T.252, H.253, D.274, S.275, S.276, F.282, N.303, G.324, Q.334, D.364
- Ligands: CPR.52
15 PLIP interactions:11 interactions with chain D, 4 interactions with chain B- Hydrogen bonds: D:H.93, D:T.252, D:T.252, D:S.276, D:N.303, D:Q.334, D:D.364, B:Q.469
- pi-Stacking: D:H.253, D:H.253, D:F.282, D:F.282
- Water bridges: B:A.46, B:A.46
- Salt bridges: B:H.466
- 60 x UNX: UNKNOWN ATOM OR ION(Non-functional Binders)
UNX.3: 1 residues within 4Å:- Ligands: UNX.4
Ligand excluded by PLIPUNX.4: 2 residues within 4Å:- Ligands: UNX.3, UNX.5
Ligand excluded by PLIPUNX.5: 2 residues within 4Å:- Ligands: UNX.4, UNX.6
Ligand excluded by PLIPUNX.6: 2 residues within 4Å:- Ligands: UNX.5, UNX.7
Ligand excluded by PLIPUNX.7: 2 residues within 4Å:- Ligands: UNX.6, UNX.8
Ligand excluded by PLIPUNX.8: 2 residues within 4Å:- Ligands: UNX.7, UNX.9
Ligand excluded by PLIPUNX.9: 2 residues within 4Å:- Ligands: UNX.8, UNX.10
Ligand excluded by PLIPUNX.10: 2 residues within 4Å:- Ligands: UNX.9, UNX.11
Ligand excluded by PLIPUNX.11: 2 residues within 4Å:- Ligands: UNX.10, UNX.12
Ligand excluded by PLIPUNX.12: 1 residues within 4Å:- Ligands: UNX.11
Ligand excluded by PLIPUNX.13: 1 residues within 4Å:- Ligands: UNX.14
Ligand excluded by PLIPUNX.14: 2 residues within 4Å:- Ligands: UNX.13, UNX.15
Ligand excluded by PLIPUNX.15: 2 residues within 4Å:- Ligands: UNX.14, UNX.16
Ligand excluded by PLIPUNX.16: 2 residues within 4Å:- Ligands: UNX.15, UNX.17
Ligand excluded by PLIPUNX.17: 1 residues within 4Å:- Ligands: UNX.16
Ligand excluded by PLIPUNX.20: 1 residues within 4Å:- Ligands: UNX.21
Ligand excluded by PLIPUNX.21: 2 residues within 4Å:- Ligands: UNX.20, UNX.22
Ligand excluded by PLIPUNX.22: 2 residues within 4Å:- Ligands: UNX.21, UNX.23
Ligand excluded by PLIPUNX.23: 2 residues within 4Å:- Ligands: UNX.22, UNX.24
Ligand excluded by PLIPUNX.24: 2 residues within 4Å:- Ligands: UNX.23, UNX.25
Ligand excluded by PLIPUNX.25: 2 residues within 4Å:- Ligands: UNX.24, UNX.26
Ligand excluded by PLIPUNX.26: 2 residues within 4Å:- Ligands: UNX.25, UNX.27
Ligand excluded by PLIPUNX.27: 2 residues within 4Å:- Ligands: UNX.26, UNX.28
Ligand excluded by PLIPUNX.28: 2 residues within 4Å:- Ligands: UNX.27, UNX.29
Ligand excluded by PLIPUNX.29: 1 residues within 4Å:- Ligands: UNX.28
Ligand excluded by PLIPUNX.30: 1 residues within 4Å:- Ligands: UNX.31
Ligand excluded by PLIPUNX.31: 2 residues within 4Å:- Ligands: UNX.30, UNX.32
Ligand excluded by PLIPUNX.32: 2 residues within 4Å:- Ligands: UNX.31, UNX.33
Ligand excluded by PLIPUNX.33: 2 residues within 4Å:- Ligands: UNX.32, UNX.34
Ligand excluded by PLIPUNX.34: 1 residues within 4Å:- Ligands: UNX.33
Ligand excluded by PLIPUNX.37: 1 residues within 4Å:- Ligands: UNX.38
Ligand excluded by PLIPUNX.38: 2 residues within 4Å:- Ligands: UNX.37, UNX.39
Ligand excluded by PLIPUNX.39: 2 residues within 4Å:- Ligands: UNX.38, UNX.40
Ligand excluded by PLIPUNX.40: 2 residues within 4Å:- Ligands: UNX.39, UNX.41
Ligand excluded by PLIPUNX.41: 2 residues within 4Å:- Ligands: UNX.40, UNX.42
Ligand excluded by PLIPUNX.42: 2 residues within 4Å:- Ligands: UNX.41, UNX.43
Ligand excluded by PLIPUNX.43: 2 residues within 4Å:- Ligands: UNX.42, UNX.44
Ligand excluded by PLIPUNX.44: 2 residues within 4Å:- Ligands: UNX.43, UNX.45
Ligand excluded by PLIPUNX.45: 2 residues within 4Å:- Ligands: UNX.44, UNX.46
Ligand excluded by PLIPUNX.46: 1 residues within 4Å:- Ligands: UNX.45
Ligand excluded by PLIPUNX.47: 1 residues within 4Å:- Ligands: UNX.48
Ligand excluded by PLIPUNX.48: 2 residues within 4Å:- Ligands: UNX.47, UNX.49
Ligand excluded by PLIPUNX.49: 2 residues within 4Å:- Ligands: UNX.48, UNX.50
Ligand excluded by PLIPUNX.50: 2 residues within 4Å:- Ligands: UNX.49, UNX.51
Ligand excluded by PLIPUNX.51: 1 residues within 4Å:- Ligands: UNX.50
Ligand excluded by PLIPUNX.54: 1 residues within 4Å:- Ligands: UNX.55
Ligand excluded by PLIPUNX.55: 2 residues within 4Å:- Ligands: UNX.54, UNX.56
Ligand excluded by PLIPUNX.56: 2 residues within 4Å:- Ligands: UNX.55, UNX.57
Ligand excluded by PLIPUNX.57: 2 residues within 4Å:- Ligands: UNX.56, UNX.58
Ligand excluded by PLIPUNX.58: 2 residues within 4Å:- Ligands: UNX.57, UNX.59
Ligand excluded by PLIPUNX.59: 2 residues within 4Å:- Ligands: UNX.58, UNX.60
Ligand excluded by PLIPUNX.60: 2 residues within 4Å:- Ligands: UNX.59, UNX.61
Ligand excluded by PLIPUNX.61: 2 residues within 4Å:- Ligands: UNX.60, UNX.62
Ligand excluded by PLIPUNX.62: 2 residues within 4Å:- Ligands: UNX.61, UNX.63
Ligand excluded by PLIPUNX.63: 1 residues within 4Å:- Ligands: UNX.62
Ligand excluded by PLIPUNX.64: 1 residues within 4Å:- Ligands: UNX.65
Ligand excluded by PLIPUNX.65: 2 residues within 4Å:- Ligands: UNX.64, UNX.66
Ligand excluded by PLIPUNX.66: 2 residues within 4Å:- Ligands: UNX.65, UNX.67
Ligand excluded by PLIPUNX.67: 2 residues within 4Å:- Ligands: UNX.66, UNX.68
Ligand excluded by PLIPUNX.68: 1 residues within 4Å:- Ligands: UNX.67
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Colby, T.D. et al., Crystal structure of human type II inosine monophosphate dehydrogenase: implications for ligand binding and drug design. Proc.Natl.Acad.Sci.USA (1999)
- Release Date
- 1999-04-12
- Peptides
- PROTEIN (INOSINE MONOPHOSPHATE DEHYDROGENASE 2): ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
BC
BD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.90 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x CPR: 6-CHLOROPURINE RIBOSIDE, 5'-MONOPHOSPHATE(Covalent)
- 4 x SAE: SELENAZOLE-4-CARBOXYAMIDE-ADENINE DINUCLEOTIDE(Non-covalent)
- 60 x UNX: UNKNOWN ATOM OR ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Colby, T.D. et al., Crystal structure of human type II inosine monophosphate dehydrogenase: implications for ligand binding and drug design. Proc.Natl.Acad.Sci.USA (1999)
- Release Date
- 1999-04-12
- Peptides
- PROTEIN (INOSINE MONOPHOSPHATE DEHYDROGENASE 2): ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
BC
BD
B